Objectives: To assess changes in haemostasis during liver resection and to
discuss the indications for antifibrinolytic therapy.
Study design: Open prospective study
Patients: The study included 39 consecutive non-cirrhotic patients presenti
ng for liver resection under portal triad clamping.
Method: General anaesthesia was obtained with thiopentone, fentanyl, vecuro
nium and isoflurane. Transfusion scheme was standardized. Aprotinin (5,000
kIU.kg(-1) BW) was administered in case of unexplained bleeding in the oper
ative field. Coagulation pattern was assessed by routine tests and thrombel
astrography before surgery, before portal triad clamping, 5 min after reper
fusion and at completion of surgery. Patients requiring aprotinin intraoper
atively were compared to others.
Results: In 32 patients no significant bleeding occurred. Their coagulation
pattern was moderately changed and remained within the normal range. In se
ven patients severe bleeding occurred which was treated with aprotinin. The
ir coagulation tests were significantly modified, especially after reperfus
ion, associating an increase in aPTT, TT, FDP, DDim, r + k and a decreased
platelet count.
Conclusion: These changes were more in favour of a dilution coagulopathy or
a DIC than hyperfibrinolysis. Therefore substitutive therapy with coagulati
on factors should be preferred to an antifibrinolytic agent. A systematic a
dministration of the latter for liver resection in non-cirrhotic patients i
s debatable, considering the allergic risk (reoperation for cancer recurren
ce), thrombosis facilitation (pedicle clamping) and high cost. (C) 1999 Els
evier, Paris.